Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
- Status
- COMPLETED
- Phase
- PHASE3
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos
- Status
- UNKNOWN
- Phase
- N/A
Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3